Safety of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant in adults

Randall Hyer, Darren K McGuire, Biao Xing, Sam Jackson, Robert Janssen

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Safety of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant in adults'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences

Social Sciences